Rubens B. Costa

Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial

Benedito A. Carneiro, Bhavana Konda, Rubens B. Costa et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 114 citations · Full text

Anaplastic Lymphoma Kinase Mutation ( <i>ALK</i> F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to Alectinib

Benedito A. Carneiro, Sahithi Pamarthy, Ami N. Shah et al. · Clinical Cancer Research · 2018 · 38 citations · Full text

Systematic review and meta-analysis of selected toxicities of approved <i>ALK</i> inhibitors in metastatic non-small cell lung cancer

Rubens B. Costa, Ricardo Costa, Sarah Talamantes et al. · Oncotarget · 2018 · 37 citations · Full text

Interstitial Pneumonitis Secondary to Trastuzumab: A Case Report and Literature Review

Ricardo Costa, Rubens B. Costa-Filho, Sarah Talamantes et al. · Case Reports in Oncology · 2017 · 20 citations · Full text

Breast Oncology, Cycle 5, Medicine +8

Analyses of selected safety endpoints in phase 1 and late-phase clinical trials of anti-PD-1 and PD-L1 inhibitors: prediction of immune-related toxicities

Ricardo Costa, Rubens B. Costa, Sarah Talamantes et al. · Oncotarget · 2017 · 19 citations · Full text

Immunotoxicology, Pd-l1 Inhibitors, Immunology +21